Table 1.

Linearity, lower limit of detection (LLOD), and lower limit of quantification (LLOQ), matrix effect (SSE) of ochratoxin A (OTA) and ochratoxin α (OTα).

Matrix	Mycotoxin	Linear Range (ng mL−1)	Slope	Intercept	R2	LLOD (ng mL−1)	LLOQ (ng mL−1)	SSE (%)
Solvent	OTA	0.1–200	12,601	275	0.999	/	/	/
	OTα	0.1–200	37,500	846	0.999	/	/	/
Milk	OTA	0.1–200	20,432	542	0.994	0.03	0.1	162
	OTα	0.1–200	21,438	1215	0.999	0.03	0.1	57
Urine	OTA	0.2–200	14,564	180	0.990	0.1	0.2	116
	OTα	0.2–200	13,428	197	0.990	0.1	0.2	36
Plasma	OTA	0.1–200	26,422	−2142	0.995	0.03	0.1	130
	OTα	0.1–200	27,476	2219	0.997	0.03	0.1	73
Heart	OTA	0.1–200	6378	810	0.997	0.03	0.1	51
	OTα	0.1–200	30,231	2037	0.994	0.03	0.1	81
Liver	OTA	0.1–200	5598	1109	0.999	0.03	0.1	44
	OTα	0.1–200	24,216	−501	0.997	0.03	0.1	65
Spleen	OTA	0.1–200	4990	636	0.998	0.03	0.1	40
	OTα	0.1–200	26,424	1424	0.993	0.03	0.1	70
Lung	OTA	0.1–200	4934	617	0.999	0.03	0.1	39
	OTα	0.1–200	22,983	1086	0.998	0.03	0.1	61
Kidney	OTA	0.1–200	5048	851	0.998	0.03	0.1	40
	OTα	0.1–200	26,374	700	0.995	0.03	0.1	70